. 2022 Nov 21;107(2):449–456. doi: 10.1097/TP.0000000000004428

TABLE 2.

Treatment for COVID-19 infection before lung transplant

Variable^a	n = 20
Remdesivir	16 (80%)
Steroid	16 (80%)
Hospital admission	20 (100%)
Discharged to home	8 (40%)
Remained hospitalized (non-ICU)	7 (35%)
Remained hospitalized (ICU)	5 (25%)
Hospital stay, d	47 ± 42
Hospital stay, d	47 (2–165)
Intubation	3 (15%)
ECMO	2 (10%)
Hemodialysis	0 (0%)
O₂ requirement postinfection, L/min	17 ± 20
O₂ requirement postinfection, L/min	6.5 (0–60)
Time from COVID-19 diagnosis to listing, d	131 ± 102
Time from COVID-19 diagnosis to listing, d	80 (38–332)
Time from COVID-19 diagnosis to lung transplant, d	163 ± 116
Time from COVID-19 diagnosis to lung transplant, d	107 (42–368)

^aContinuous variables are shown as mean ± SD and median (range). Categorical variables are shown as absolute numbers (percentages).

COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit.